SSSteven L. Shein

Steven L. Shein

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Steven L. Shein has a total of 228 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Vancomycin population pharmacokinetics and exposure variability in children with multiple organ dysfunction syndrome

    by Marc H. Scheetz, Justin Shiau, Victor Amajor, Amanda Bwint, Anna Sharova, Josey Hensley, Steven L. Shein, Janet R. Hume, Courtney M. Rowan, Carolina Quintana Grijalba, et al.

  • Prevalence and Risk Factors of Adverse Events in Procedural Sedation Outside the Operating Room for Pediatric Dental Procedures

    by William Sanislow, Anne Stormorken, David K. Ngendahimana, David Speicher, Kelly Kirtland, Maia Wiesenfeld, Steven L. Shein

    OBJECTIVES: To determine the prevalence and risk factors of adverse events (AE) in pediatric patients undergoing procedural sedation outside of the operating room (PSOOR) for dental procedures. DESIGN: A retrospective analysis of prospectively collected data using the Pediatric Sedation Research Consortium database, which collects multicenter, quality-controlled data on pediatric sedations. SETTING: Twenty-five participating hospitals across the United States, with data collected from July 1, 2020, to June 30, 2024. PATIENTS: Three thousand five hundred forty-eight pediatric patients undergoing PSOOR for dental procedures. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: The primary outcome was the occurrence of one or more AEs, which were classified as either severe (including both critical and high-risk events) or low-risk based on severity. Thirty-one percent of dental sedations had an AE occur and 5% had a severe AE occur. The most prevalent severe events in dental sedations included complete airway obstruction (2.8%), hypoxia requiring major intervention (1.6%), and laryngospasm (0.8%). Multiple modeling approaches revealed that medication regimen, provider type, neurologic comorbidity, snoring, and obesity were associated with severe AEs after adjusting for confounding variables. CONCLUSIONS: While PSOOR is generally safe, children undergoing sedation for dental procedures experience high rates of AEs, most commonly airway-related complications. Patient-, provider-, and institution-level factors may increase the risk of AEs. These findings underscore the need for enhanced preprocedural risk assessment and provider training to ensure safety in pediatric dental sedation practices.

  • Characteristics of Young Children Hospitalized With Acute Respiratory Failure From Infection With Respiratory Syncytial Virus, SARS-CoV-2, or Both, November 2023–March 2024

    by Regina M Simeone, Margaret M Newhams, Laura D Zambrano, Jemima M Calixte, Katherine Lindsey, Amber Orzel-Lockwood, Amanda B Payne, Natasha B Halasa, Satoshi Kamidani, Aline B Maddux, et al.

    Background: Respiratory syncytial virus (RSV) and SARS-CoV-2 can cause acute respiratory failure in children. We compared characteristics and outcomes of children aged <2 years with respiratory failure from infection with RSV, SARS-CoV-2, or both viruses. Methods: We used data from a US pediatric respiratory virus hospitalization surveillance network including children with ICU admission for acute respiratory failure (receiving high-flow oxygen or mechanical ventilation) with RSV and/or SARS-CoV-2 during November 2023–March 2024. Demographic, clinical characteristics, and hospitalization outcomes were stratified by a positive test for RSV, SARS-CoV-2, or both viruses, and compared using chi-squared or Kruskal–Wallis tests. Multivariable analyses assessed independent associations between outcomes and infection. Results: Overall, 1406 children were included: 1253 (89.1%) for RSV, 105 (7.5%) for COVID-19, and 48 (3.4%) with RSV + SARS-CoV-2 detected. Children with RSV or RSV + SARS-CoV-2 had lower median ages (3.9 and 5.4 months, respectively) compared with those with SARS-CoV-2 (8.8 months; P < .001). Twenty percent of children with RSV and 43.8% with COVID-19 had an underlying medical condition. Among infants aged <1 year for whom preterm status was available, 31.5% with RSV and 50% with COVID-19 had either prematurity or a comorbidity. Children with SARS-CoV-2 were more likely to require invasive mechanical ventilation, receive vasoactive infusions, and die compared with RSV with and without SARS-CoV-2. Conclusions: Critically ill children <2 years of age infected with SARS-CoV-2 had more severe illness presentation and outcomes and were older compared with those with RSV and RSV + SARS-CoV-2 codetection. Most children were previously healthy, highlighting the need for prevention measures.

  • Open Access

    Managing Critical Bronchiolitis

    by David G. Speicher, Steven L. Shein


  • Kindergarten Readiness Assessment Scores in Children who Received Early Life Mechanical Ventilation in the Pediatric Intensive Care Unit

    by Steven L. Shein, Alena D'ALessio, Lena Baker, Meredith Fischer, Robert Fischer, Deanne Wilson-Costello, Aline B Maddux, Francisca Garcia-Cobian Richter

    The impact of prolonged sedative medication usage on cognitive outcomes of young pediatric intensive care unit (PICU) patients has been incompletely assessed. We aim to assess the feasibility of linking an electronic medical record (EMR) system and a regional database to evaluate performance on standardized testing among PICU survivors. This is a single-center data-linkage study between EMR records and the Child and Household Integrated Longitudinal Data (CHILD) system, which links individual-level data across 35 administrative systems including Kindergarten Readiness Assessment (KRA) scores. The study was performed at a tertiary PICU in Cleveland, Ohio, United States with children born in 2011 or 2012 who received invasive mechanical ventilation and sedation before the age of 3 years in our PICU. We evaluated rate of “on-track” KRA scores, chronic absenteeism, and repeat kindergarten in the study population compared with a propensity score matched cohort from CHILD. Of 182 eligible PICU patients, 98 (54%) had a record identified in CHILD, and 32 had KRA scores available and sufficient data for propensity score matching. Compared with 160 matched controls, PICU patients had a lower rate of “on-track” scores (7/32 [22%] vs 102/160 [64%], p < 0.001) and more chronic absenteeism (14/32 [44%] vs. 34/160 [22%], p = 0.007). There was no difference in rates of repeat kindergarten (8/32 [25%] vs. 36/160 [23%], p = ;−0.759). We determined that linking hospital EMR records to regional databases is a feasible method to explore PICU outcomes. Additional studies are needed to confirm our preliminary finding of poor performance compared with matched controls.

  • Association of Interventions With Outcomes in Children At-Risk for Pediatric Acute Respiratory Distress Syndrome: A Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology Study*

    by Grant S. Hamill, Kenneth E. Remy, Katherine N. Slain, Colin J. Sallee, Robinder Khemani, Lincoln Smith, Steven L. Shein, on behalf of the Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology (PARDIE) Investigators and the Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network

    Objectives: Describe the frequency with which transfusion and medications that modulate lung injury are administered to children meeting at-risk for pediatric acute respiratory distress syndrome (ARF-PARDS) criteria and evaluate for associations of transfusion, fluid balance, nutrition, and medications with unfavorable clinical outcomes. Design: Secondary analysis of the Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology study, a prospective point prevalence study. All enrolled ARF-PARDS patients were included unless they developed subsequent pediatric acute respiratory distress syndrome (PARDS) within 24 hours of PICU admission or PICU length of stay was less than 24 hours. Univariate and multivariable analyses were used to identify associations between therapies given during the first 2 calendar days after ARF-PARDS diagnosis and subsequent PARDS diagnosis (primary outcome), 28-day PICU-free days (PFDs), and 28-day ventilator-free days (VFDs). Setting: Thirty-seven international PICUs. Patients: Two hundred sixty-seven children meeting Pediatric Acute Lung Injury Consensus Conference ARF-PARDS criteria. Interventions: None. Measurements and Main Results: During the first 2 days after meeting ARF-PARDS criteria, 55% of subjects received beta-agonists, 42% received corticosteroids, 28% received diuretics, and 9% were transfused. Subsequent PARDS (15%) was associated with platelet transfusion (n = 11; adjusted odds ratio: 4.75 [95% CI 1.03–21.92]) and diuretics (n = 74; 2.55 [1.19–5.46]) in multivariable analyses that adjusted for comorbidities, PARDS risk factor, initial oxygen saturation by pulse oximetry:Fio 2 ratio, and initial type of ventilation. Beta-agonists were associated with lower adjusted odds of subsequent PARDS (0.43 [0.19–0.98]). Platelets and diuretics were also associated with fewer PFDs and fewer VFDs in the multivariable models, and TPN was associated with fewer PFDs. Corticosteroids, net fluid balance, and volume of enteral feeding were not associated with the primary or secondary outcomes. Conclusions: There is an independent association between platelet transfusion, diuretic administration, and unfavorable outcomes in children at risk for PARDS, although this may be related to treatment bias and unmeasured confounders. Nevertheless, prospective evaluation of the role of these management strategies on outcomes in children with ARF-PARDS is needed.


  • Open Access

    Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-C

    by Juanjie Tang, Tanya Novak, Julian Hecker, Gabrielle Grubbs, Fatema Tuz Zahra, Lorenza Bellusci, Sara Pourhashemi, Janet Chou, Kristin Moffitt, Natasha B. Halasa, et al.